Managing RIsk , Patient Safety and Best Practice 2/2

Managing RIsk , Patient Safety and Best Practice 2/2 –

Biggest Movers On News: Francesca's Holdings Corp (FRAN), Nanosphere, Inc …
The company said the database for the BEMA Buprenorphine Phase 3 clinical study in opioid naive patients with chronic pain will be locked by mid-2014, with results following shortly thereafter, by BDSI's partner, Endo Pharmaceuticals, triggering a $ 10 …
Read more on iStreetWire

Find More Buprenorphine Treatment Information…

2 Responses to “Managing RIsk , Patient Safety and Best Practice 2/2”

TheIRETAchannel:

January 23, 2014 at 3:54 am

Thanks for watching! Glad to connect with people knowledgeable about
medication assisted treatment all over the map.
TheIRETAchannel:

January 23, 2014 at 4:52 am

Thanks for watching. We’re always interested in what’s happening across the
pond. And glad to connect with others in the field.